Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
Saffari, Afshin
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. [electronic resource] - Orphanet journal of rare diseases 05 2019 - 96 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1750-1172
10.1186/s13023-019-1077-6 doi
Autism Spectrum Disorder--drug therapy
Child
Child, Preschool
Cholesterol--blood
Cholinesterases--blood
Epilepsy--drug therapy
Everolimus--therapeutic use
Female
Humans
Immunosuppressive Agents--therapeutic use
Infant
Infant, Newborn
Male
Multicenter Studies as Topic
Phosphates--blood
Retrospective Studies
TOR Serine-Threonine Kinases--antagonists & inhibitors
Triglycerides--blood
Tuberous Sclerosis--drug therapy
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. [electronic resource] - Orphanet journal of rare diseases 05 2019 - 96 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1750-1172
10.1186/s13023-019-1077-6 doi
Autism Spectrum Disorder--drug therapy
Child
Child, Preschool
Cholesterol--blood
Cholinesterases--blood
Epilepsy--drug therapy
Everolimus--therapeutic use
Female
Humans
Immunosuppressive Agents--therapeutic use
Infant
Infant, Newborn
Male
Multicenter Studies as Topic
Phosphates--blood
Retrospective Studies
TOR Serine-Threonine Kinases--antagonists & inhibitors
Triglycerides--blood
Tuberous Sclerosis--drug therapy